Global Transcatheter Mitral valve Replacement Market, By Product (mechanical valve and Bioprosthetic tissue valve), By Diagnostic test (lateral flow assay, PCR assay, latex Agglutination tests),By End-user (hospital, clinics and others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Between the left atrium and the left ventricle is the mitral valve. Mitral valve disorder occurs when the valve fails to operate correctly, resulting in abnormal blood flow. Mitral valve prolapse and regurgitation are two diseases caused by this abnormal blood flow. Transcatheter mitral valve replacement (TMVR) has emerged as an alternative treatment choice for serious mitral regurgitation in patients who are unable or unwilling to undergo surgery. With a low rate of residual mitral regurgitation and low transvalvular gradients, transcatheter mitral valve replacement produces excellent hemodynamic performance. As the field of transcatheter mitral valve replacement (TMVR) advances and grows, using the heart team approach to define and individualise the most suitable care for each patient will become a vital part of assessing patients with mitral valve disease. The Transcatheter Mitral valve replacement market accounted for US$ 0.92  billion in 2020 and is estimated to be US$ 14.5 billion by 2030 and is anticipated to register a CAGR of 31.4%.

Impact of Covid-19 pandemic on market

The COVID 19 pandemic has put a strain on healthcare systems and intensive care unit  capability, causing many procedures to be halted, including transcatheter mitral  valve replacement .

Growth in business operations by emerging and small sized players

The demand is growing due to an increase in the geriatric population and an increase in mitral valve disorders. Other factors that contribute to market growth include technological advances and the launch of novel mitral valves. Percutaneous transcatheter mitral valve replacement is a practical and relatively safe choice for patients with mitral regurgitation. These approaches are proving to be useful for patients who are at risk of developing mitral valve disease in terms of protection and effectiveness. The increasing demand for this technique is boosting the global transcatheter mitral valve implantation market's growth prospects over the forecast period.

The transcatheter mitral valve replacement market is segmented based on product, application, end-use, and region.

On the basis of product, the Transcatheter mitral valve replacement market is segmented into mechanical valves and Bioprosthetic tissue valves. Based on application, the target market is segmented into mitral valve stenosis, mitral valve prolapse and mitral valve regurgitation. On the basis of end-use, the target market is segmented into hospitals, ambulatory surgical centers, diagnostic centers and others.

Regional Insights:   

On region the Transcatheter mitral valve replacement market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global transcatheter mitral valve repair and replacement market was dominated by North America. This is due to improved healthcare facilities as well as increased understanding of mitral valve diseases and the advantages of mitral valve repair and replacement.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Transcatheter mitral valve replacement market report based on product, application, end-use and region.

Transcatheter Mitral valve replacement Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the Transcatheter Mitral valve replacement market includes Abbott Laboratories, Biotronik Pvt Ltd, Colibri Heart Valve, LLC, Edward Lifesciences, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., NeoChord, Venus Medtech, Transcatheter Technologies GmbH, MValve Technologies and Mardil Medical.

• Abbott laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Biotronik Pvt Ltd
• Colibri Heart Valve
• Edward Lifesciences
• HLT Medical
• LivaNova Plc
• Medtronic Plc
• Neovasc Inc.
• NeoChord
• Venus Medtech
• Transcatheter Technologies GmbH
• MValve Technologies
• Mardil Medical.

“*” marked represents similar segmentation in other categories in the respective section